Search research articles
Contact Us
Filters
Showing results (111-120 of 201) with videos related to
Page
of 21
Sort By:
Food and Drug Law Journal
|
May 26, 1999
Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface
K E Warner, C C Peck, R L Woosley, et al.
Circulation
|
May 1, 1983
Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine
H J Duff, D Roden, R K Primm, et al.
Circulation
|
September 15, 1996
Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart
M D Drici, T R Burklow, V Haridasse, et al.
JAMA
|
March 20, 2001
Drug-induced QT prolongation in women during the menstrual cycle
I Rodriguez, M J Kilborn, X K Liu, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1994
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome
D A Flockhart, D J Clauw, E B Sale, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1988
Block and enhancement of cardiac ion channel currents by des-oxo-amiodarone
P B Bennett, G Kabalka, T T Kennedy, et al.
Biochemical Pharmacology
|
May 30, 2001
Testosterone-mediated modulation of HERG blockade by proarrhythmic agents
Y M Shuba, V E Degtiar, V N Osipenko, et al.
British Journal of Clinical Pharmacology
|
August 1, 1990
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism
C Funck-Brentano, D J Silberstein, D M Roden, et al.
The American Journal of Cardiology
|
September 1, 1984
Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog
A K Dawson, D M Roden, H J Duff, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1982
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium
R L Woosley, S B Reele, D M Roden, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 201) with videos related to
Sort By:
Page
of 21
Food and Drug Law Journal
|
May 26, 1999
Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface
K E Warner, C C Peck, R L Woosley, et al.
Circulation
|
May 1, 1983
Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine
H J Duff, D Roden, R K Primm, et al.
Circulation
|
September 15, 1996
Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart
M D Drici, T R Burklow, V Haridasse, et al.
JAMA
|
March 20, 2001
Drug-induced QT prolongation in women during the menstrual cycle
I Rodriguez, M J Kilborn, X K Liu, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1994
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome
D A Flockhart, D J Clauw, E B Sale, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1988
Block and enhancement of cardiac ion channel currents by des-oxo-amiodarone
P B Bennett, G Kabalka, T T Kennedy, et al.
Biochemical Pharmacology
|
May 30, 2001
Testosterone-mediated modulation of HERG blockade by proarrhythmic agents
Y M Shuba, V E Degtiar, V N Osipenko, et al.
British Journal of Clinical Pharmacology
|
August 1, 1990
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism
C Funck-Brentano, D J Silberstein, D M Roden, et al.
The American Journal of Cardiology
|
September 1, 1984
Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog
A K Dawson, D M Roden, H J Duff, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1982
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium
R L Woosley, S B Reele, D M Roden, et al.
Page
of 21